Pain Management Drugs Market Size, Growth Report, Emerging Trends, Industry Forecast & Major Company
Global Pain Management
Drugs Market
Pain management drugs are
defined as specific drug classes that have pharmacological actions on pain
receptors & work against the pain symptoms. These drugs can be used for
pain management of conditions, as indicated on label & some drugs have
off-label uses. For example, antidepressants & anticonvulsants were
originally used for the management of depression & epilepsy respectively.
However, these drugs have shown activity against pain indications & are
prescribed for pain management as off-label indication.
Growing geriatric
population is the main factor which drives global pain management drugs market
growth, as geriatric people are more to suffer from joint as well as other
chronic conditions. Also, the increase in prevalence of chronic diseases like
diabetes, cancer, and osteoarthritis will positively influence the market
growth. In addition, the increase in number of surgical procedures and growing
healthcare expenditure are expected to propel the global pain management drugs
market growth.
Get Request Sample copy @ https://qualiketresearch.com/request-sample/Pain-Management-Drugs-Market/request-sample
Furthermore, lack of
alternative treatment therapies is expected to boost the target market growth
throughout the forecast period. For instance, in 2015, Depomed, Inc. has
acquired the United States rights to NUCYNTA ER (tapentadol), NUCYNTA
(tapentadol), extended-release tablets & NUCYNTA (tapentadol) oral solution
from Janssen Pharmaceuticals, Tapentadol is available in solution, tablet, and
extended-release forms. Moreover, the solution & tablet forms of NUCYNTA
have three patents, out of which one expired in the June 2017 and remaining two
will expire in June 2025 & August 2029, respectively. Moreover, patent
expiry of pain management drugs like Oxycontin, Opana, Celebrex (2013 - 2014),
and others are creating opportunity to key players for introducing new products
in the market.
Life threatening side
effects associated with pain management medications & addiction issues with
opioid drugs are expected to hamper the global pain management drugs market
growth over the forecast period. Also, lack of research and development
activities by major players are anticipated to hinder global pain management
market growth.
Impact of COVID-19
The COVID-19 crisis is
expected to impact the pain management drugs market in the initial phase of
over the forecast period. The pandemic has stressed healthcare systems across
the globe, so many clinics & pain services are no longer open for public
services, due to safety measures imposed by governments. Also, during the
latter half of the forecast period, demand for pain management drugs is
expected to increase, owing to numerous factors including telemedicine, which
is an appropriate & effective way to provide necessary medical services to
patients with chronic pain.
Market Segmentation
The global pain management
market is segmented into pain type such as Acute, and Chronic, by drug class
such as NSAIDs, Anticonvulsants, Anesthetics, Antidepressants, Anti-migraine
Agents, Opioids, and Nonnarcotic Analgesics. Further, market is segmented into
indication such as Arthritic Pain, Neuropathic Pain, Chronic Back Pain,
Postoperative Pain, Migraine, Muscle sprain/strain, Acute appendicitis, and
Others.
Also, the Global Pain
Management Drugs Market is segmented into five regions such as North
America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
Regional Analysis
The North America region
accounted for majority of pain management drug market share in the year 2019,
and it is anticipated to remain dominant over the forecast period. Due to the
increase in geriatric population and favorable regulatory conditions. The increase
in number of drug abuse cases & additive nature of opioid has reduced use
of prescriptions for opioid in the region. Moreover, the APAC region is
expected to experience highest growth rate throughout the forecast period, due
to presence of larger patient pool and the rise in healthcare experience in the
region.
Market Key Players
Various key operating
players are listed in this report such as Novartis AG, Abbott Laboratories, Eli
Lilly & Company, Endo Health Solutions, Inc., Pfizer, Inc., Merck & Co.
Inc., Johnson & Johnson, GlaxoSmithKline Plc., Purdue Pharma L.P., Mylan
NV., etc.
Market Taxonomy
By Pain Type
- Acute
- Chronic
By Drug Class
- NSAIDs
- Anticonvulsants
- Anesthetics
- Antidepressants
- Anti-migraine Agents
- Opioids
- Nonnarcotic Analgesics
By Indication
- Arthritic Pain
- Neuropathic Pain
- Chronic Back Pain
- Postoperative Pain
- Migraine
- Muscle sprain/strain
- Acute appendicitis
- Others
By Region
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East & Africa
Browse full report @ https://qualiketresearch.com/reports-details/Pain-Management-Drugs-Market
About
Us
QualiKet Research is a leading Market Research and
Competitive Intelligence partner helping leaders across the world to develop
robust strategy and stay ahead for evolution by providing actionable insights
about ever changing market scenario, competition and customers. QualiKet
Research is dedicated to enhancing the ability of faster decision making by
providing timely and scalable intelligence. We use different intelligence tools
to come up with evidence that showcases the threats and opportunities which
help our clients outperform their competition.
Comments
Post a Comment